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Inhibition of endoplasmic reticulum 
stress improves coronary artery 
function in the spontaneously 
hypertensive rats
Soo-Kyoung Choi, Mihwa Lim, Seon-Hee Byeon & Young-Ho Lee
Endoplasmic reticulum (ER) stress has been shown to play a critical role in the pathogenesis of 
cardiovascular complications. However, the role and mechanisms of ER stress in hypertension 
remain unclear. Thus, we hypothesized that enhanced ER stress contributes to the maintenance 
of hypertension in spontaneously hypertensive rats (SHRs). Sixteen-week old male SHRs and 
Wistar Kyoto Rats (WKYs) were used in this study. The SHRs were treated with ER stress inhibitor 
(Tauroursodeoxycholic acid; TUDCA, 100 mg/kg/day) for two weeks. There was a decrease in systolic 
blood pressure in SHR treated with TUDCA. The pressure-induced myogenic tone was significantly 
increased, whereas endothelium-dependent relaxation was significantly attenuated in SHR compared 
with WHY. Interestingly, treatment of ER stress inhibitor normalized myogenic responses and 
endothelium-dependent relaxation in SHR. These data were associated with an increase in expression 
or phosphorylation of ER stress markers (Bip, ATF6, CHOP, IRE1, XBP1, PERK, and eIF2α) in SHRs, 
which were reduced by TUDCA treatment. Furthermore, phosphorylation of MLC20 was increased in 
SHRs, which was reduced by the treatment of TUDCA. Therefore, our results suggest that ER stress 
could be a potential target for hypertension.
Hypertension is one of the leading causes for cardiovascular disease worldwide. A contributing factor to hyper-
tension is elevated vascular tone in small arteries and arterioles. Although increasing number of studies have been 
investigating the augmented vascular tone in the hypertension, the exact mechanism remains unclear. Recently, 
few studies have reported a link between endoplasmic reticulum (ER) stress and hypertension. However, it is 
limited to show endothelium derived contracting factor (EDCF)-mediated signaling in aorta1 and carotid artery2.
The ER is a specialized organelle responsible for the synthesis, assembly, folding, and sorting of proteins. 
When ER homeostasis is perturbed, the unfolded protein response occurs to perform corrective functions that 
challenges ER function, such as inflammation, disruption of calcium homeostasis, and alterations in cellular 
redox status, leads to an accumulation of misfolded proteins3,4. To re-establish ER homeostasis, cells activate the 
unfolded protein response (UPR) involving attenuation of translation, up-regulation of ER chaperones, increased 
protein degradation, transcriptional activation5,6. The UPR is initiated by activation of three distinct sensors at 
the ER membrane, including inositol-requiring enzyme-1 (IRE1), PKR-like ER kinase (PERK), and activating 
transcription factor-6 (ATF6)7. Engagement of UPR sensors triggers changes in downstream signaling such as 
X-box binding protein 1 (XBP1), CCAAT-enhancer-binding protein homologous protein (CHOP), eukaryotic 
translation initiation factor 2 subunit alpha (eIF2α ), which leads to the up-regulation of various UPR target genes 
to restore ER homeostasis8. Recently, alterations of the function in the ER have been reported as a contributing 
factor to pathophysiology of several diseases including cancer9, neurodegenerative diseases10,11, and diabetes12,13.
Tauroursodeoxycholic acid (TUDCA) is a hydrophilic bile acid that is normally produced endogenously in 
the liver14. TUDCA has long been used as a bile acid replacement therapy for the treatment of cholestasis and 
hepatocellular necrosis15. Recently, its effects have been reported in pulmonary hypertension16 and cardiovas-
cular disease such as myocardial contractile dysfunction17, myocarditis16–18. However, the modulatory effects of 
TUDCA in hypertension remain unclear. Therefore, the present study investigated whether ER stress is increased 
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in the coronary arteries of spontaneously hypertensive rats (SHRs) and treatment of TUDCA could alleviate the 
increased ER stress and normalize the elevated blood pressure in SHRs.
Results
Effect of ER stress Inhibition on Body Weight and Blood Pressure. There were no significant 
differences in body weight between groups (WKY: 342.75 ± 4.13 g, SHR: 332.5 ± 3.06 g, SHR + TUDCA: 
335.0 ± 4.916 g; at the end of experiments, Fig. 1a,b). Blood pressure was significantly higher in SHRs com-
pared to WKYs. Interestingly, ER stress inhibitor significantly reduced the blood pressure in SHRs (WKY: 
107.75 ± 2.49 mmHg, SHR: 209.25 ± 4.46 mmHg, SHR + TUDCA: 148.0 ± 3.24 mmHg; at the end of experi-
ments, Fig. 1c,d).
Effect of ER Stress Inhibition on Myogenic Response and Endothelium Dependent Relaxation 
in Coronary Arteries. The myogenic response and endothelium-dependent relaxation were measured to 
evaluate the vascular reactivity in isolated coronary arteries. Myogenic response was significantly augmented 
in coronary arteries from SHRs compared to WKYs and was significantly reduced by the treatment of ER stress 
inhibitor (Fig. 2a). Endothelium-dependent relaxation was significantly impaired in coronary arteries from SHRs 
compared to WKYs. Interestingly, treatment of TUDCA significantly improved endothelium-dependent relaxa-
tion in coronary arteries from SHRs (Fig. 2b).
Effect of ER stress Inhibition on Expression and Phosphorylation of ER Stress Sensors. To 
determine whether ER stress is increased in the coronary arteries of SHRs and whether the treatment of TUDCA 
decrease ER stress, we observed the expression and/or phosphorylation of ER stress marker proteins. We found 
that expression of BiP was significantly enhanced in SHRs compared to WKYs (Fig. 3a). And phosphorylation 
Figure 1. Effects of the ER stress inhibition on body weight and blood pressure in WKYs and SHRs.  
(a,b) Comparison of body weight between WKYs and SHRs with or without TUDCA (n = 5) showing time 
course of changes (a) and at the end of the experiment (b). (b) Comparison of systolic blood pressure levels 
between WKYs and SHRs with or without TUDCA (n = 5) showing time course of changes (c) and at the end  
of the experiment (d). *p < 0.05 for WKYs vs. SHRs, #p < 0.05 for SHRs vs. SHRs with TUDCA.
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of IRE1 and expression of XBP1 were increased in SHRs (Fig. 3b,c). Interestingly, inhibition of ER stress with 
TUDCA decreased up-regulation of these sensors (Fig. 3a–c). Furthermore, cleaved ATF6 and expression of 
CHOP were increased in coronary arteries of SHR, which is normalized by treatment of TUDCA (Fig. 3d,e). 
Phosphorylated PERK and eIF2α were also increased in SHRs compared to WKYs and were suppressed by the 
treatment with TUDCA (Fig. 3f,g). These results provide evidence that treatment with TUDCA effectively inhib-
ited ER stress in SHRs and all three branches of UPR process were associated the ER stress in SHRs. To confirm 
western blot data, we performed immunofluorescence staining of ER stress markers in isolated coronary arteries. 
We found that phosphorylation of eIF2α (Fig. 4a) and CHOP (Fig. 4b) were significantly increased in the isolated 
coronary arteries from the SHRs compared to arteries from WKYs. In accordance with western blot analysis, 
inhibition of ER stress with TUDCA decreased up-regulation of these marker proteins (Fig. 4a,b).
Effect of ER stress Inhibition on Phosphorylation of Myosin Light Chain. Since vascular tone is 
determined by phosphorylation of MLC20, we investigated whether MLC20 phosphorylation is increased in cor-
onary arteries from SHRs and affected by treatment of TUDCA. The phosphorylation of MLC20 at Ser19 in SHRs 
was significantly augmented compared to WKYs, and reduced by treatment of TUDCA (Fig. 5).
Discussion
In the present study, we found that ER stress contributes to vascular dysfunction in hypertension. The main find-
ings of this study are (1) ER stress inhibitor, TUDCA, decreased blood pressure in SHRs; (2) myogenic response 
and endothelium-dependent relaxation were impaired in coronary arteries from SHRs and the inhibition of ER 
stress normalized myogenic response and endothelium-dependent relaxation in SHRs; (3) the ER stress sensors 
were up-regulated in the coronary arteries from SHRs, which were reduced by treatment of TUDCA; (4) phos-
phorylation of MLC20 was increased in SHRs, and were decreased by TUDCA treatment. These results suggest 
that increased ER stress is responsible for coronary artery dysfunction in SHRs, likely through up-regulation of all 
three UPR branches including PERK, ATF6, and IRE1. Furthermore, these results were associated with ER stress 
inhibition decreased phosphorylation of MLC20 which is the determinant of vascular tone.
Hypertension is the major risk factor of cardiovascular disease. It has been suggested that an increased periph-
eral resistance is the fundamental hemodynamic disorder in hypertension19. The increased peripheral resistance 
of hypertension is due to a defective mechanism in the contractility of vessels and structural alterations of ves-
sel walls. Several studies reported that calcification and consequent structural changes of the vessel wall occur 
in coronary artery disease20,21. In the present study, we focused on investigating the vascular contractility in 
coronary arteries of hypertensive animals. Vascular reactivity is mainly controlled by myogenic response and 
endothelium-dependent relaxation mechanisms. Myogenic response is defined by vasoconstriction in response 
to an increase of intravascular pressure and vasodilation in response to a decrease in intravascular pressure, and is 
an intrinsic vascular response which plays an important role in the local regulation of blood flow22. Previous stud-
ies have reported that arterial function is impaired due to the elevated myogenic response in hypertensive rats23,24. 
Interestingly, in the present study, we observed that enhanced myogenic response in coronary artery of SHRs 
associated with increased ER stress sensors. Thus, ER stress inhibition using pharmacological approach reduced 
enhanced myogenic response. Vascular reactivity is also regulated by endothelium-dependent relaxation. In this 
study, we found that endothelium-dependent relaxation was impaired in coronary arteries from SHRs, which is 
Figure 2. Effects of the ER stress inhibition on myogenic response and endothelium-dependent relaxation 
in coronary arteries from WKYs and SHRs. (a) The summarized data for the effects of ER stress inhibition 
on pressure-induced myogenic response. Changes in inner diameter were measured in response to 20 mmHg 
stepwise increases in intraluminal pressure in the K-H solution (active diameter) or Ca2+ free K-H solution 
(passive diameter). (n = 5). (b) Summarized data for endothelium-dependent relaxation in response to 
cumulative doses of acetylcholine (10−9 to 10−5 mol/L) in the coronary arteries pre-contracted with U-46619 
(10−7 mol/L). *p < 0.05 for WKYs vs. SHRs, #p < 0.05 for SHRs vs. SHRs with TUDCA (n = 5).
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in accordance with previous reports1,25. Moreover, treatment of ER stress inhibitor, TUDCA normalized impaired 
endothelium-dependent relaxation in SHRs. To further demonstrate which UPR components are involved in the 
ER stress induced vascular dysfunction in SHRs, we observed expression and phosphorylation of the ER stress 
sensor proteins. The BiP is an intracellular chaperone, and regulates the UPR to protect cells from apoptosis under 
stress condition26. In the present study, we observed that BiP was up-regulated in SHR and significantly reduced 
by the treatment with TUDCA. It has also been established that three unique pathways comprise the UPR. In 
each branch, IRE1, PERK, and ATF6 sense abnormal conditions in the ER lumen and transmit the information 
across the membrane into the cytosol where a series of transcription factors carry information to the nucleus26. In 
the current study, we observed that enhanced phosphorylation of IRE1 and its downstream XBP1 expression in 
SHRs compared to WKYs. Furthermore, phosphorylation of PERK and eIF2α were also elevated in SHRs, which 
is reduced by the treatment with TUDCA. In addition, we observed that cleaved ATF6 and CHOP are increased 
in coronary arteries of SHRs, which is also decreased by the treatment of TUDCA. It has been observed the con-
tribution of each ER stress sensor branches, ATF6-CHOP, IRE1-XBP1, and PERK-eIF2α in several diseases27,28. 
However, is has not been reported which ER stress sensors are related with vascular dysfunction in coronary 
arteries of SHR. Thus, this is the first study to demonstrate the UPR mechanisms responsible for coronary artery 
dysfunction in SHRs. We clarified that all the branches of UPR sensors contribute vascular dysfunction on SHRs.
Vascular smooth muscle contraction is primarily regulated by phosphorylation at Ser19 of the MLC2029. And 
it has been reported that MLC20 phosphorylation is increased in arteries of hypertensive animal models30,31. 
However it is not known that ER stress is involved in the regulation of MLC20 phosphorylation. In the pres-
ent study, we observed that enhanced phosphorylation of MLC20 was significantly reduced by the treatment of 
TUDCA. However, direct link between MLC20 phosphorylation and ER stress signaling was not investigated in 
this study. Further experiments are needed to define how the ER stress affects phosphorylation of MLC20.
Figure 3. Effects of TUDCA on the expression or phosphorylation of ER stress sensors. Representative 
western blot analysis and quantitative data for BiP expression (a), phosphorylated IRE1 and XBP1 expression 
(b,c); cleaved ATF6 and CHOP (d,e); phosphorylated PERK and phosphorylated eIF2α (f,g) in all groups. 
(n = 4) *p < 0.05 for WKYs vs. SHRs, #p < 0.05 for SHRs vs. SHRs with TUDCA.
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Figure 4. Effects of TUDCA on the expression or phosphorylation of ER stress markers in the isolated 
coronary arteries. Immunofluorescence of phosphorylated eIF2α and α -smooth muscle actin (a), and CHOP 
and α -smooth muscle actin (b). The arrows show positive staining.
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In the present study, we found that ER stress was associated with vascular dysfunction in coronary arter-
ies of SHRs. The inhibition of ER stress by TUDCA reduced blood pressure in SHRs, which are associated 
with improvement of vascular reactivity. These data are in accordance with the previous study demonstrated 
that ER stress induction may contribute to increases in blood pressure, which is associated with the enhanced 
EDCF response in the aorta of the SHRs1. In addition, it has been also reported that inhibition of ER stress 
with Berberine improves endothelial function in carotid arteries of SHRs2. However, limitations of these stud-
ies are that they showed the involvement of ER stress in large vessels such as aorta1 and carotid artery2 using 
tension measurements. In contrast, we performed the study with coronary arteries using pressurized arterio-
graph which has more physiological relevance. In conclusion, we suggest that ER stress is exacerbated in SHRs 
and inhibition of ER stress normalizes increased blood pressure, augmented myogenic responses, and impaired 
endothelium-dependent relaxation, due to decreased phosphorylation of MLC20 which are associated with reduc-
tion of ER stress sensors such as Bip, ATF6, CHOP, IRE1, XBP1, PERK, and eIF2α pathways.
The major limitation of our study is that the improvement of vascular function in SHRs treated with TUDCA 
may be secondary to the systemic administration of TUDCA which acts in the central nervous system. It has been 
suggested that systemic administration of ER stress inhibitors could reduce blood pressure due to the inhibition 
of ER stress in the subfornical organ (SFO)32,33. Thus, it is not clear whether TUDCA have a primary effect on the 
reduction of blood pressure in SHRs. Therefore, additional experiments are needed to describe the local effects 
and underlying mechanisms. Furthermore, how the UPR components affect the MLC20 phosphorylation was 
not examined in the present study. Thus, further studies are needed to investigate whether ER stress inhibition 
affects the regulation of myosin light chain kinase (MLCK) or myosin light chain phosphatase (MLCP), which 
determines the level of MLC20 phosphorylation. Despite the limitations of this study, this is the first study to show 
the effect of ER stress inhibition in the coronary artery dysfunction in SHRs. Moreover, we showed which UPR 
pathways are related with the vascular dysfunction and consequent high blood pressure in SHRs. Thus, our study 
provides new approach for the treatment of hypertension.
Methods
All experiments were performed according to the Guide for the Care and Use of Laboratory Animals published 
by US National Institutes of Health (NIH publication, 8th Edition, 2011) were approved by the Ethics Committee 
and the Institutional Animal Care and Use Committee of Yonsei University, College of Medicine.
Animal Models. Sixteen to eighteen weeks old male wistar kyoto rats (WKYs) and spontaneously hyper-
tensive rats (SHRs) were used in this study. Rats were divided into three groups: (1) WKYs with no treatment 
Figure 5. Effects of TUDCA on the phosphorylation of MLC20 at Ser19. The representative western blot 
analysis and quantitative data for phosphorylation of MLC20. (n = 4) *p < 0.05 for WKYs vs. SHRs, #p < 0.05 for 
SHRs vs. SHRs with TUDCA.
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(n = 10); (2) SHRs with no treatment (n = 10); (3) SHRs who received ER stress inhibitor (n = 10, TUDCA, 
150 mg/kg/day, intra-peritoneal injection for two weeks). The body weight and blood pressure were measured 
every other day. At the end of the treatment period rats were anesthetized with isoflurane via a nose cone for 
euthanasia. The depth of anesthesia was monitored by pinching the toes, and no reaction was taken as a confirma-
tion of proper anesthesia. Then, hearts were isolated and immediately placed in ice-cold Krebs-Henseleit (K-H) 
solution (composition in mmol/L: NaCl, 119; CaCl2, 2.5; NaHCO3, 25; MgSO4, 1.2; KH2PO4, 1.2; KCl, 4.6; and 
glucose, 11.1) and processed for the further studies.
Blood Pressure Measurement. Blood pressure (BP) was measured in the warmed, conscious, restrained 
state by using the tail-cuff method using a photoplethysmography blood pressure monitoring system (BP-2000, 
Visitech Systems, Apex, NC, USA). Animals were trained to the apparatus for 1 week, before recordings were 
collected. At each time point, at least 10 readings were obtained for each rat and the average of the readings 
taken.
Preparation of Isolated Coronary Arteries. After 2 weeks of treatment, rats were sacrificed and heart 
was immediately excised and placed into ice-cold K-H solution. The left anterior descending coronary arteries 
were isolated, dissected (segments length ~2 mm), cannulated with glass micropipettes, and perfused with K-H 
solution bubbled with a 95% O2 + 5% CO2 gas mixture to maintain pH of 7.4 at 36 °C. The vessels were pressur-
ized to 40 mm Hg using pressure-servo control perfusion systems (Living Systems Instruments, St Albans, VT, 
USA) for a 40-minute equilibration period. A video image analyzer, as described previously34, monitored the 
vessel diameter. Intraluminal pressure was increased from 20 to 120 mmHg in a stepwise manner to measure 
myogenic responses. At the end of the experiments, vessels were incubated with a calcium-free K-H solution con-
taining calcium chelating agent, ethylene glycol tetraacetic acid (EGTA, 1 mM) and Ca2+ channel blocker, nifed-
ipine (5 μ M) to determine passive diameter. Myogenic response is calculated as the percentage between active and 
passive diameters. To determine the endothelium-dependent relaxation, pressurized arteries were pre-contracted 
with thromboxane agonist (U-46619, 10−7 mol/L), and then cumulative concentrations (10−9 to 10−5 mol/L) of 
acetylcholine were applied.
Western Blot Analysis. Freshly isolated coronary arteries from all of the groups were immediately frozen 
in liquid nitrogen and then homogenized in ice-cold lysis buffer, as previously described35. Western blot anal-
ysis was performed for BiP (binding immunoglobulin protein; 1:1000 dilution; Cell signaling, Danvers, MA, 
USA), phosphorylated IRE1, XBP-1 (1:1000 dilution; Cell signaling, Danvers, MA, USA), phosphorylated-eIF2α 
(1:1000 dilution; Abcam, Cambridge, MA, USA), cleaved ATF6 (1:1000 dilution; Cell signaling, Danvers, MA 
USA), CHOP (1:1000 dilution; Cell signaling, Danvers, MA, USA), and phosphorylated PERK (1:1000; Cell 
Signaling, Danvers, MA, USA), and phosphorylated 20 KDa myosin light chain (MLC20, 1:1000; Cell Signaling, 
Danvers, MA, USA). Blots were stripped and then reprobed with the β -actin antibody (1:2000 dilution; Santa 
Cruz Biotechnology, Dallas, TX, USA) to verify the equal loading between the samples.
Immunofluorescence staining of ER stress markers in coronary artery. The expression of CHOP 
and phosphorylated eIF2α in the isolated coronary arteries were measured using immunofluorescence staining 
as described previously30. Briefly, after 2 weeks of treatment, rats were sacrificed and coronary arteries were 
isolated, as described above, were immediately embedded in OCT, and were frozen in liquid nitrogen. Serial 
5-μ m-thick sections, were collected. For immunofluorescence staining, the sections were incubated with 
α - smooth muscle actin antibody and CHOP or phospho-eIF2α at 4 °C overnight. Antibody binding was visual-
ized by streptavidin conjugated-Alexa Fluor 555 (red) and Alexa Fluor 488 (green) (Molecular Probes, Eugene, 
OR, USA). Nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI; Vectashield mounting 
media,Vector Laboratories, Burlingame, CA, USA).
Drugs. The following drugs were used: U-46619 (Tocris Bioscience, Bristol, UK); acetylcholine chloride 
(Sigma-Aldrich, St Louis, MO, USA), TUDCA (Calbiochem, Darmstadt, Germany); the general laboratory rea-
gents (Sigma-Aldrich, St Louis, MO, USA)
Statistical Analysis. Results are expressed as mean ± SEM. One-way or 2-way ANOVA was used to compare 
each parameter when appropriate. Comparisons between groups were performed with t-tests when there was a 
significant F-statistic on a one-way or 2-way ANOVA. Values of P < 0.05 were considered significant. Differences 
between specified groups were analyzed using the Student t test (2-tailed) for comparing 2 groups, with P < 0.05 
considered statistically significant.
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